BIOMAT Database Logo BIOMAT Database Logo

Influence of a platelet-activating factor antagonist on circulating levels of cyclosporine in the dog. 1988

F L Tse, and H T Smith
Department of Drug Metabolism, Sandoz Research Institute, East Hanover, NJ 07936.

UI MeSH Term Description Entries
D008297 Male Males
D010975 Platelet Aggregation Inhibitors Drugs or agents which antagonize or impair any mechanism leading to blood platelet aggregation, whether during the phases of activation and shape change or following the dense-granule release reaction and stimulation of the prostaglandin-thromboxane system. Antiaggregants, Platelet,Antiplatelet Agent,Antiplatelet Agents,Antiplatelet Drug,Blood Platelet Aggregation Inhibitor,Blood Platelet Antagonist,Blood Platelet Antiaggregant,PAR-1 Antagonists,Platelet Aggregation Inhibitor,Platelet Antagonist,Platelet Antagonists,Platelet Antiaggregant,Platelet Antiaggregants,Platelet Inhibitor,Protease-Activated Receptor-1 Antagonists,Antiplatelet Drugs,Blood Platelet Aggregation Inhibitors,Blood Platelet Antagonists,Blood Platelet Antiaggregants,Platelet Inhibitors,Agent, Antiplatelet,Aggregation Inhibitor, Platelet,Antagonist, Blood Platelet,Antagonist, Platelet,Antiaggregant, Blood Platelet,Antiaggregant, Platelet,Drug, Antiplatelet,Inhibitor, Platelet,Inhibitor, Platelet Aggregation,PAR 1 Antagonists,Platelet Antagonist, Blood,Platelet Antiaggregant, Blood,Protease Activated Receptor 1 Antagonists
D011806 Quinolinium Compounds Compounds, Quinolinium
D002851 Chromatography, High Pressure Liquid Liquid chromatographic techniques which feature high inlet pressures, high sensitivity, and high speed. Chromatography, High Performance Liquid,Chromatography, High Speed Liquid,Chromatography, Liquid, High Pressure,HPLC,High Performance Liquid Chromatography,High-Performance Liquid Chromatography,UPLC,Ultra Performance Liquid Chromatography,Chromatography, High-Performance Liquid,High-Performance Liquid Chromatographies,Liquid Chromatography, High-Performance
D003524 Cyclosporins A group of closely related cyclic undecapeptides from the fungi Trichoderma polysporum and Cylindocarpon lucidum. They have some antineoplastic and antifungal action and significant immunosuppressive effects. Cyclosporins have been proposed as adjuvants in tissue and organ transplantation to suppress graft rejection. Cyclosporines
D004285 Dogs The domestic dog, Canis familiaris, comprising about 400 breeds, of the carnivore family CANIDAE. They are worldwide in distribution and live in association with people. (Walker's Mammals of the World, 5th ed, p1065) Canis familiaris,Dog
D000818 Animals Unicellular or multicellular, heterotrophic organisms, that have sensation and the power of voluntary movement. Under the older five kingdom paradigm, Animalia was one of the kingdoms. Under the modern three domain model, Animalia represents one of the many groups in the domain EUKARYOTA. Animal,Metazoa,Animalia

Related Publications

F L Tse, and H T Smith
Effect of platelet-activating factor antagonist on cyclosporine nephrotoxicity. Glomerular hemodynamics evaluation.
April 1989, Transplantation,
F L Tse, and H T Smith
Influence of a platelet-activating factor antagonist on severe pancreatitis in two experimental models.
October 1992, International journal of pancreatology : official journal of the International Association of Pancreatology,
F L Tse, and H T Smith
The platelet-activating factor antagonist WEB 2170. Its beneficial effect on dog renal allograft survival.
October 1993, Transplantation,
F L Tse, and H T Smith
Dual effects of a novel thienodiazepine platelet-activating factor antagonist, on drug-oxidizing enzymes in beagle dog.
April 1994, Xenobiotica; the fate of foreign compounds in biological systems,
F L Tse, and H T Smith
Preventive effect of platelet-activating factor antagonist, Y-24180, against cyclosporine-induced acute nephrotoxicity.
January 2001, Life sciences,
F L Tse, and H T Smith
Modulation of in vitro immune reactions by platelet activating factor and a platelet activating factor antagonist.
January 1988, Immunopharmacology,
F L Tse, and H T Smith
Clinical significance of circulating platelet-activating factor acetylhydrolase levels in systemic sclerosis.
April 2012, Archives of dermatological research,
F L Tse, and H T Smith
Platelet activating factor antagonist activity of ginsenosides.
January 1998, Biological & pharmaceutical bulletin,
F L Tse, and H T Smith
Increased levels of platelet-activating factor in blood following intestinal ischemia in the dog.
January 1989, Biochemical and biophysical research communications,
F L Tse, and H T Smith
Treatment with a platelet-activating factor antagonist has little protective effects during endotoxic shock in the dog.
September 1997, Shock (Augusta, Ga.),
Copied contents to your clipboard!